Invesco Ltd. G1 Therapeutics, Inc. Transaction History

Invesco Ltd.

  • $460 Billion
  • Q2 2024

A detailed history of Invesco Ltd. transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 35,709 shares of GTHX stock, worth $255,319. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,709
Holding current value
$255,319
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$2.2 - $4.98 $78,559 - $177,830
35,709 New
35,709 $81,000
Q3 2023

Nov 13, 2023
BUY
$1.22 - $2.67 $8,261 - $18,081
6,772 Added 48.63%
20,697 $29,000
Q2 2023

Aug 11, 2023
BUY
$2.46 - $3.14 $2,484 - $3,171
1,010 Added 7.82%
13,925 $34,000
Q1 2023

May 12, 2023
BUY
$2.57 - $8.16 $4,600 - $14,606
1,790 Added 16.09%
12,915 $34,000
Q4 2022

Feb 13, 2023
SELL
$5.19 - $13.5 $529,047 - $1.38 Million
-101,936 Reduced 90.16%
11,125 $60,000
Q3 2022

Nov 14, 2022
BUY
$5.17 - $16.99 $584,525 - $1.92 Million
113,061 New
113,061 $1.41 Million
Q2 2022

Aug 15, 2022
SELL
$4.04 - $8.51 $65,076 - $137,079
-16,108 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$7.6 - $11.02 $65,063 - $94,342
-8,561 Reduced 34.7%
16,108 $122,000
Q4 2021

Feb 14, 2022
SELL
$10.16 - $16.17 $22,971 - $36,560
-2,261 Reduced 8.4%
24,669 $252,000
Q3 2021

Nov 15, 2021
BUY
$13.16 - $22.47 $35,742 - $61,028
2,716 Added 11.22%
26,930 $362,000
Q2 2021

Aug 17, 2021
BUY
$19.57 - $26.32 $115,599 - $155,472
5,907 Added 32.27%
24,214 $531,000
Q1 2021

May 17, 2021
SELL
$17.58 - $32.59 $11.6 Million - $21.4 Million
-657,173 Reduced 97.29%
18,307 $441,000
Q4 2020

Feb 16, 2021
BUY
$10.99 - $20.4 $3.82 Million - $7.1 Million
347,896 Added 106.2%
675,480 $12.2 Million
Q3 2020

Nov 16, 2020
BUY
$11.55 - $23.75 $978,030 - $2.01 Million
84,678 Added 34.86%
327,584 $3.78 Million
Q2 2020

Aug 14, 2020
SELL
$9.57 - $24.37 $255,289 - $650,094
-26,676 Reduced 9.9%
242,906 $5.89 Million
Q1 2020

May 15, 2020
BUY
$9.07 - $26.32 $337,131 - $978,314
37,170 Added 15.99%
269,582 $2.97 Million
Q4 2019

Feb 14, 2020
SELL
$20.54 - $31.0 $303,992 - $458,800
-14,800 Reduced 5.99%
232,412 $6.14 Million
Q3 2019

Nov 14, 2019
BUY
$22.78 - $40.58 $4.73 Million - $8.43 Million
207,790 Added 527.09%
247,212 $5.63 Million
Q2 2019

Aug 14, 2019
SELL
$16.03 - $31.1 $496,946 - $964,131
-31,001 Reduced 44.02%
39,422 $1.21 Million
Q1 2019

May 15, 2019
BUY
$14.4 - $21.45 $537,220 - $800,235
37,307 Added 112.66%
70,423 $1.17 Million
Q4 2018

Feb 14, 2019
BUY
$16.51 - $51.33 $546,745 - $1.7 Million
33,116 New
33,116 $634,000

Others Institutions Holding GTHX

# of Institutions
101
Shares Held
20.1M
Call Options Held
1.87M
Put Options Held
1.18M
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email